WGBH's Morning Edition host Bob Seay spoke with Northeastern law professor and WGBH Legal Analyst Daniel Medwed to discuss the recent efforts by Biogen, a Cambridge-based leader in the life sciences field, to file a flurry of lawsuits against competitors to protect its patents related to its blockbuster multiple sclerosis drug, Tecfidera.